Platelets were genetically modified to express surface-bound tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to inhibit tumor cell metastasis by targeting the interaction between autologous platelets and migrating tumor cells. The gene discussed is TNFSF10; the disease is neoplasm.